Pharma Major Lupin has received US Food and Drug Administration (US FDA) nod for Pioglitazone Hydrochloride Tablets. Pioglitazone tablets are to treat high blood sugar associated with diabetes.
Earlier in March, the company received final approval for its Doxycycline Capsules USP, 50 mg, 75 mg, and 100 mg from the United States Food and Drugs Administration (US FDA) to market a generic version of Aqua Pharmaceuticals' Monodox Capsules 50 mg, 75 mg, and 100 mg.
Lupin is an innovation led transnational pharmaceutical company producing and developing a wide range of branded and generic formulations and APIs globally.
